Navigation Links
Hard To Treat Diseases (HTDS) exclusive agent and partner of NCPC
Date:8/11/2009

llion doses   Hepatitis B vaccine 51 million doses   Measles vaccine 34 million doses   BCG vaccine 17 million doses

The aforementioned statistics and data were obtained from the following sources without permission

   http://bioplanassociates.com (Direct link bellow)
   
http://bioplanassociates.com/publications/articles/VACCINES_China_Zhou_Apr07_C
hinaB.pdf

The HTDS management sees this agent agreement as a great potential boost of its revenue streams in introducing International marketing of Recombinant Hepatitis B Vaccine(CHO) to Mellow Hope's already existing distribution network.

In other company news, the company IP progress, Q2 financials and other corporate business matters are in the process of undergoing final review. These will be filed shortly and followed with an announcement.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of vari
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
5. Free distribution of insecticide-treated mosquito nets can save lives
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
10. Non-medicinal treatment touted for pre-schoolers with ADHD
11. Nonmedicinal treatment touted for preschoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... and dying hospitalized children ask their physicians to pray ... to such personal requests? While increasing numbers of physicians ... families cope with serious illness, a new study reports ... who raise the issue of prayer, not the doctors ... Medical Journal , Brandeis and Rice University sociologists report ...
(Date:12/16/2009)... agency, is honored to announce that Chris Wepfer and Jackie ... Year in Healthcare Traveler magazine’s 2009 Recruiters of the Year ... received such honors and the first for Jackie. , ... ... Solutions, a national healthcare staffing agency, is honored to announce ...
(Date:12/16/2009)... For ages, people from around the world have visited ... waters have a reputation that dates back over 2000 ... Now, with the introduction of two bath salt lines ... legendary benefits of Dead Sea salt in their own ... Dead Sea salt and essential oils - but no ...
(Date:12/16/2009)... BOCA RATON, Fla., Dec. 16 Dale Buchanan, owner ... has decided to have a weight loss contest for his ... is that the students are not competing for their own ... to raise money for the Tri County Humane Society ... each student of mine loses between January 4 and February ...
(Date:12/16/2009)... access to patient information could improve care, but ... 16 (HealthDay News) -- U.S. physicians support the ... exist about privacy problems, two new studies show. ... practice and specialist doctors in Massachusetts found that ... would improve patient quality of care, 70 percent ...
Breaking Medicine News(10 mins):Health News:Prayer on the hospital floor 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:Pros and Cons of Electronic Medical Records Weighed 2
... Shows Stellar 92 Percent Effective Rate; First For ... lice" become more resistant to some pharmaceutical remedies, ... all-natural head lice product line, Rosemary Repel Hair ... preventing lice from infesting hair follicles.In an in-vitro ...
... is reduced in rodent models of liver injury, ... sulphide, two factors that contribute to endothelial dysfunction ... study the analysis of the human Cystathionase gene ... sequence. Administration of an FXR ligand to carbon ...
... peptide (NP) receptor type B (NPR-B) gene was ... diabetic rats and the expression was increased in ... pGC-cGMP signal is up-regulated and it may contribute ... , Gastroparesis (delayed gastric emptying) is frequent in ...
... Practice and an alliance of businesses in Bucks County, ... and their staff more time to devote to patient ... to help doctors in Bucks County better handle the ... Members of the Bucks County Partners include Doylestown Hospital, ...
... Fixed-dose combination offers a convenient option that may ... pressure goals while decreasing patient pill burden(1)PARSIPPANY, N.J., ... that the United States Food and Drug Administration ... and olmesartan medoxomil) as initial or ,first-line, therapy ...
... Inc. (Nasdaq: GTIV ), a leading provider of ... present at the Deutsche Bank 34th Annual Health Care Conference ... May 19, 2009. The presentations will be available to the ... accessed by visiting http://investors.gentiva.com/events.cfm . ...
Other Medicine News:Health News:'Super Lice' Repelled by All-Natural Products First Ever Independent Study Shows 2Health News:Farnesoid X receptor regulates cystathionase 2Health News:NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 3Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 2Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 3Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 5Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 6Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 2Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 3
(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...
(Date:12/16/2009)... Mass., Dec. 16 According to Millennium ... technology market intelligence, health care reforms in China ... market in 2009, and will continue to fuel ... Asia Pacific Markets for Interventional Cardiology Devices ... the Chinese government will allow the Chinese drug-eluting ...
(Date:12/16/2009)... /PRNewswire/ -- Sanofi Pasteur, the ... today that it has entered into an ... develop and commercialize its prophylactic vaccine against ... aureus or MRSA. MRSA are responsible ... referred to as multidrug-resistant Staphylococcus aureus ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 1Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 2Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 3Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 1Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 2LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 1LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 2
... the 2009 ASCO MeetingINDIANAPOLIS, May 30 Semafore ... and development company, today presented data from a ... pan-PI3K/mTORC1/2 inhibitor, SF1126, at the 2009 American Society ... in Orlando, Florida.Dr. E. Gabriela Chiorean, from the ...
... 3 study has demonstrated that Induction Chemotherapy ... in comparison to standard ChemoRadiotherapy alone -MADRID, ... Neck Cancer Cooperative Group (TTCC) announced today ... standard ChemoRadiotherapy (CRT), a treatment paradigm defined ...
Other Medicine Technology:Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 2Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 3Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 2Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 3
... for ELISA testing. The system consists of ... Robot, and 1 Plate hotel. The Dade ... of samples from primary tubes via the ... robotic transport system and plate processing via ...
... The Genesis RMP is ideal for ... as for reference and pharmaceutical laboratories. It ... available ELISA and EIA assays from different ... annual throughput of up to 600'000 tests, ...
... IMMULITE and IMMULITE 1000 assays ... the IMMULITE and IMMULITE 1000, ... which offer simplicity in both ... can be found in a ...
... ENA Enzyme-Linked Immunosorbent Assay (ELISA) is intended for ... La, Scl-70, and Jo-1 in human sera. ... detect antibodies in a single serum specimen. ... used as an aid to the diagnosis of ...
Medicine Products: